Hsa_circ_0072732 enhances sunitinib resistance of renal cell carcinoma by inhibiting ferroptosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Hsa_circ_0072732 enhances sunitinib resistance of renal cell carcinoma by inhibiting ferroptosis ; volume:15 ; number:1 ; day:23 ; month:11 ; year:2024 ; pages:1-13 ; date:12.2024
Discover oncology ; 15, Heft 1 (23.11.2024), 1-13, 12.2024
- Creator
-
Tian, Xiaorui
Liu, Jun
Yi, Cheng
You, Xiangyun
Yuan, Chunli
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12672-024-01580-2
- URN
-
urn:nbn:de:101:1-2502092106526.161795181196
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tian, Xiaorui
- Liu, Jun
- Yi, Cheng
- You, Xiangyun
- Yuan, Chunli
- SpringerLink (Online service)
Other Objects (12)
Hsa_circ_0000497 and hsa_circ_0000918 contributed to peritoneal metastasis of ovarian cancer via ascites
A novel circRNA, hsa_circ_0069382, regulates gastric cancer progression
Salivary Circular RNAs Hsa_Circ_0001874 and Hsa_Circ_0001971 as Novel Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma
Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3
Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
Identification of Plasma hsa_circ_0001230 and hsa_circ_0023879 as Potential Novel Biomarkers for Focal Segmental Glomerulosclerosis and circRNA-miRNA-mRNA Network Analysis
Hsa_circ_0006010 and hsa_circ_0002903 in peripheral blood serve as novel diagnostic, surveillance and prognostic biomarkers for disease progression in chronic myeloid leukemia
Hsa_Circ_0001275: A Potential Novel Diagnostic Biomarker for Postmenopausal Osteoporosis
Retraction Note: Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer
Hsa_circ_0046264 up-regulated BRCA2 to suppress lung cancer through targeting hsa-miR-1245
Correction: CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer
Hsa_circ_0000497 and hsa_circ_0000918 contributed to peritoneal metastasis of ovarian cancer via ascites
A novel circRNA, hsa_circ_0069382, regulates gastric cancer progression
Salivary Circular RNAs Hsa_Circ_0001874 and Hsa_Circ_0001971 as Novel Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma
Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3
Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
Identification of Plasma hsa_circ_0001230 and hsa_circ_0023879 as Potential Novel Biomarkers for Focal Segmental Glomerulosclerosis and circRNA-miRNA-mRNA Network Analysis
Hsa_circ_0006010 and hsa_circ_0002903 in peripheral blood serve as novel diagnostic, surveillance and prognostic biomarkers for disease progression in chronic myeloid leukemia
Hsa_Circ_0001275: A Potential Novel Diagnostic Biomarker for Postmenopausal Osteoporosis
Retraction Note: Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer
Hsa_circ_0046264 up-regulated BRCA2 to suppress lung cancer through targeting hsa-miR-1245
Correction: CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer
Hsa_circ_0000497 and hsa_circ_0000918 contributed to peritoneal metastasis of ovarian cancer via ascites
A novel circRNA, hsa_circ_0069382, regulates gastric cancer progression
Salivary Circular RNAs Hsa_Circ_0001874 and Hsa_Circ_0001971 as Novel Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma
Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3
Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
Identification of Plasma hsa_circ_0001230 and hsa_circ_0023879 as Potential Novel Biomarkers for Focal Segmental Glomerulosclerosis and circRNA-miRNA-mRNA Network Analysis
Hsa_circ_0006010 and hsa_circ_0002903 in peripheral blood serve as novel diagnostic, surveillance and prognostic biomarkers for disease progression in chronic myeloid leukemia
Hsa_Circ_0001275: A Potential Novel Diagnostic Biomarker for Postmenopausal Osteoporosis
Retraction Note: Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer
Hsa_circ_0046264 up-regulated BRCA2 to suppress lung cancer through targeting hsa-miR-1245